Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences to Present At the CIBC World Markets 18th Annual Healthcare Conference, Lazard Capital Markets 4th Annual Healthcare Conference and the 19th Annual Piper Jaffray Health Care Conference
PLAINSBORO, N.J., Oct 29, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at three conferences in New York City next month. On Monday, November 5th, the company will present at CIBC World Markets
View HTML
Toggle Summary Integra LifeSciences Acquires IsoTis Creating a Global Leader in Orthobiologics
PLAINSBORO, N.J., Oct 29, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it has acquired the shares of IsoTis, Inc. for $7.25 in cash per share of IsoTis common stock, representing total consideration to IsoTis stockholders of
View HTML
Toggle Summary Integra LifeSciences to Host Analyst Forum On November 20, 2007
PLAINSBORO, N.J., Oct 15, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will host an Analyst Forum on Tuesday, November 20, 2007 at 3:00 PM Eastern Time at the New York Marriott East Side Hotel in New York City.
View HTML
Toggle Summary Integra LifeSciences Partners With TomoTherapy to Deliver Image-Guided Stereotactic Radiosurgery
PLAINSBORO, N.J., Oct 11, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, Inc., has entered into a strategic alliance with TomoTherapy Incorporated (Nasdaq:TTPY).
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Friday, November 9, 2007 to Discuss Third Quarter 2007 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J., Oct 2, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Friday, November 9, 2007 to discuss financial results for the third quarter ended September 30, 2007 and to update
View HTML
Toggle Summary Integra LifeSciences Announces Launch of New Cortical Stimulator for Mapping Brain Functions in Cancer and Epilepsy Patients
PLAINSBORO, N.J., Sep 21, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced the release of the OCS2 Ojemann Cortical Stimulator at this week's annual meeting of the Congress of Neurological Surgeons in San Diego, CA.
View HTML
Toggle Summary Integra LifeSciences Launches Bone-Cutting Selector SaberTip At 2007 Congress of Neurological Surgeons Meeting
New Tip Significantly Expands CUSA Selector System's Applications
View HTML
Toggle Summary Integra LifeSciences Announces Poster Presentation 'Periradicular Lumbar Fibrosis: What to Do?' At 2007 Congress of Neurological Surgeons Annual Meeting
PLAINSBORO, N.J., Sep 17, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) is pleased to announce the poster presentation "Periradicular Lumbar Fibrosis: What to Do?" by Dr. Inaki Arrotegui, of the Department of Neurosurgery, University of
View HTML
Toggle Summary Integra LifeSciences to Present At the UBS Global Life Sciences Conference and Natixis Bleichroeder's Hidden Gems Conference
PLAINSBORO, N.J., Sep 17, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is scheduled to present at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Wednesday, September 26, 2007, and at Natixis
View HTML
Toggle Summary Integra NeuroSciences Launches DuraGen XS Dural Regeneration Matrix
PLAINSBORO, N.J., Sep 16, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market the DuraGen XS(TM) Dural
View HTML